Association of a 27-bp repeat polymorphism in intron 4 of endothelial constitutive nitric oxide synthase gene with hypertension in a Tunisian population

Clinical Biochemistry

Volumn 42, Issue 9, 2009, Pages 852-856

  Jemaa, Riadh ^a   Ali, Samir Ben ^a   Kallel, Amani ^a   Feki, Moncef ^a   Elasmi, Monia ^a   Taieb, Samah Haj ^a   Sanhaji, Haïfa ^a   Omar, Souheil ^a   Kaabachi, Naziha ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Genetics; Hypertension; Nitric oxide synthase; Polymorphism

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROL GROUP; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM REPEAT;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; INTRONS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; TUNISIA;

EID: 67349139914     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.12.002     Document Type: Article

References (44)

1. Forte P., Copland M., Smith L.M., Milne E., Sutherland J., and Benjamin N. Basal nitric oxide synthase in essential hypertension. Lancet 349 (1997) 837-842
2. Huang P.L., Huang Z., Mashimo H., Bloch K.D., Moskowitz M.A., Bevan J.A., et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377 (1995) 239-242
3. Wang X.L., Sim A.S., Badenhop R.F., McCredie R.M., and Wilcken D.E. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 2 (1996) 41-45
4. Ichihara S., Yamada Y., Fujimura T., Nakashima N., and Yokota M. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 81 (1998) 83-86
5. Hingorani A.D., Liang C.F., Fatibene J., et al. A common variant of the endothelial nitric oxide synthase (Glu298Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100 (1999) 1515-1520
6. Hibi K., Ishigami T., Tamura K., et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 32 (1998) 521-526
7. Yoshimura M., Yasue H., Nakayama M., et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103 (1998) 65-69
8. Yoshimura M., Yasue H., Nakayama M., et al. Genetic risk factors for coronary artery spasm; significance of endothelial nitric oxide synthase gene T-786 → C and missense Glu298Asp variants. J Invest Med 48 (2000) 367-374
9. Ghilardi G., Biondi M.L., DeMonti M., et al. Independent risk factor for moderate to severe internal carotid artery stenosis: T786C mutation of the endothelial nitric oxide synthase gene. Clin Chem 48 (2002) 989-993
10. Ogawa H., Motoyama T., Saito Y., Ogawa Y., Miyamoto Y., and Nakao K. T-786 → C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99 (1999) 2864-2870
11. Takaoka M. NOS gene polymorphism. Nippon Rinsho 62 (2004) 103-109
12. Miyamoto Y., Saito Y., Kajiyama N., et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32 (1998) 3-8
13. Shoji M., Tsutaya S., Saito R., Takamatu H., and Yasujima M. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sci 66 (2000) 2557-2562
14. Uwabo J., Soma M., Nakayama T., and Kanmatsuse K. Association of a variable number of tandem repeats in the endothelial constitutive nitric oxide synthase gene with essential hypertension in Japanese. Am J Hypertens 11 (1998) 125-128
15. Jachymova M., Horky K., Bultas J., et al. Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Commun 284 (2001) 426-430
16. -786 C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension 39 (2002) 919-922
17. Benjafield A.V., and Morris B.J. Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am J Hypertens 13 (2000) 994-998
18. Karvonen J., Kauma H., Kervinen K., et al. Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population based cohort. J Intern Med 251 (2002) 102-110
19. Tsujita Y., Baba S., Yamauchi R., et al. Association analyses between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: the Suita study. J Hypertens 19 (2001) 1941-1948
20. Jemaa R., Kallel A., Ben Ali S., et al. Association of a 27-bp repeat polymorphism in intron 4 of endothelial constitutive nitric oxide synthase gene with myocardial infarction in Tunisian patients. Clin Chem Lab Med 45 (2007) 1476-1480
21. Wang X.L., Sim A.S., Wang M.X., Murrell G.A., Trudinger B., and Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett 471 (2000) 45-50
22. Pulkkinen A., Viitanen L., Kareinen A., Lehto S., Vauhkonen I., and Laakso M. Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. J Mol Med 78 (2000) 372-379
23. Yokoyama K., Tsukada T., Nakayama M., et al. An intron 4 gene polymorphism in endothelial cell nitric oxide synthase might modulate volume-dependent hypertension in patients on hemodialysis. Nephron 85 (2000) 232-237
24. World Health Organisation. International society of hypertension guideline for the management of hypertension. J Hypertens 17 (1999) 151-183
25. World Health Organisation. Physical status: the use and interpretation antropometry: Report of a WHO expert commitee, WHO Technical Report Series, no. 854, pp 321-344. WHO: Geneva 1995.
26. National Institutes of Health National Heart Lung and Blood Institute Obesity. Education Initiative. Expert panel on the identification, evaluation, and treatment of overweight and obesity in adults. 98-4083; 1998: 1-226.
27. Marcadet A., O'Connel P., and Cohen D. Standardized Southern blot workshop techniques. In: Dupont B. (Ed). Histocompatibility Testing (1987), Springer, New York, 587-590
28. Wang X.L., Sim A.S., Badenhop R.F., McGredie R.M., and Wilken D.E. A smoking-dependent risk of coronary artery disease associated with polymorphism of the endothelial nitric oxide synthase gene. Nat Med 2 (1996) 41-45
29. Rodriguez-Esparragon F.J., Rodriguez-Perez J.C., Macias-Reyes A., and Alamo-Santara F. Peroxisome proliferator-actived receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase 4a/b gene polymorphisms are associated with essential hypertension. J Hypertens 21 (2003) 1649-1655
30. Shoji M., Tsutaya S., Saito R., Takamatu H., and Yasujima M. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sci 66 (2000) 2557-2562
31. Jeerooburkhan N., Jones L.C., Bujac S., et al. Genetic and environmental determinants of plama nitrogen oxides and risk of ischemic heart disease. Hypertension 38 (2001) 1054-1061
32. Zintzaras E., Kitsios G., and Stefanidis I. Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 48 (2006) 700-710
33. Kunnas T.A., Ilveskoski E., Niskakangas T., et al. Association of the endothelial nitric oxide synthase gene polymorphism with risk of coronary artery disease and myocardial infarction in middle-aged men. J Mol Med 80 (2002) 65-69
34. Tsukada T., Yokoyama K., Arai T., et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite concentrations in humans. Biochem Biophys Res Commun 245 (1998) 190-193
35. Wang X.L., Mahaney M.C., Sim A.S., Wang J., Blangero J., Almasy L., et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 17 (1997) 3147-3153
36. Linder L., Kiowski W., Buhler F.R., and Lücher T.F. Indirect evidence for release of endothelium-derived relaxing factor in human foream circulation in vivo: blunted response in essential hypertension. Circulation 81 (1990) 1762-1767
37. Panza J.A., Quyyumi A.A., Brush J.E., and Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323 (1990) 22-27
38. Lücher T.F., Raij L., and Vanhoutte P. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 9 (1987) 157-163
39. Meidell R.S. Southeastern internal medicine conference: endothelial dysfunction and vascular disease. Am J Med Sci 305 (1994) 378-389
40. Dminiczak A.F., and Bohr D.F. Nitric oxide and its putative role in hypertension. Hypertension 25 (1995) 1202-1211
41. Wang J., Dudley D., and Wang X.L. Haplotype-specific effects on endothelial NO synthase promotor efficiency: modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol 22 (2002) e1-4
42. White R.P., Deane C., Vallance P., and Markus H.S. Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia. Stroke 29 (1998) 467-472
43. Calver A., Collier J., and Vallance P. Forearn blood flow responses to a nitric oxide synthase unhibitor in patients with treated essential hypertension. Cardiovasc Res 28 (1994) 1720-1725
44. Shesely E.G., Maeda N., Kim H.S., et al. Elevated blood pressure in mice lacking endothalial nitric oxide synthase. Proc Natl Acad Sci USA 93 (1996) 13176-13181